Copertina

From Therapeutic Drug Monitoring To Drug Management: IMPDH Activity As Novel Surrogate Marker For Dose Adjustment Of Mycophenolate In Immunosuppressive Therapy

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autori principali:	Manfred Küpper, Rana Hallak
Natura:	Recurso digital
Lingua:	inglese
Pubblicazione:	Zenodo 1970
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients With Extrarenal Systemic Lupus Erythematosus—A Systematic Review and Meta‐Analysis
di: Zahraa Qamhieh, et al.
Pubblicazione: (2026)

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study
di: Janka Kovács, et al.
Pubblicazione: (2026)

Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails
di: Niels A. D. Guchelaar, et al.
Pubblicazione: (2024)

Enhancing the β ‐Oxidation‐Like Pathway for the Optimal Production of the Immunosuppressant Mycophenolic Acid
di: Baoqiang Fan, et al.
Pubblicazione: (2025)

Enhancing the β-Oxidation-Like Pathway for the Optimal Production of the Immunosuppressant Mycophenolic Acid.
di: Fan, Baoqiang, et al.
Pubblicazione: (2025)

Predictive Markers for Response to Immunosuppressive Therapy in Aplastic Anaemia
di: Maya Gupta, et al.
Pubblicazione: (2025)

Therapeutic Drug Monitoring of Oral Oncology Drugs: Another Example of Maslow's Hammer
di: Mark J. Ratain
Pubblicazione: (2024)

Advancing Therapeutic Drug Monitoring for Oral Targeted Anticancer Drugs: From Hospital‐Based Towards Home‐Sampling
di: Marinda Meertens, et al.
Pubblicazione: (2025)

IMPDH2's Central Role in Cellular Growth and Diseases: A Potential Therapeutic Target
di: Zheng Li, et al.
Pubblicazione: (2025)

Microbiome‐Informed Dosing: Exploring Gut Microbial Communities Impact on Mycophenolate Enterohepatic Circulation and Therapeutic Target Achievement
di: Abdelrahman Saqr, et al.
Pubblicazione: (2025)

Recent Trends in Therapeutic Drug Monitoring of Peptide Antibiotics
di: Zuzana Kilianova, et al.
Pubblicazione: (2024)

Therapeutic Drug Monitoring for Dose Optimization of Infliximab in Patients With Inflammatory Bowel Disease: An Analysis of Canadian Real‐World Data
di: David C. Sealey, et al.
Pubblicazione: (2025)

Capillary Blood Self‐Sampling for Therapeutic Drug Monitoring: A Mixed‐Methods Usability Study of the True Dose ® Kit
di: Marie-Therése Crafoord, et al.
Pubblicazione: (2025)

A Dose‐Aware Model for Revealing Dose‐Risk Relationship of Drug–Drug Interaction
di: Yi Shi, et al.
Pubblicazione: (2025)

Impact of Drug Conjugation Site and Corona Chemistry on the Therapeutic Activity of Polymer Nanorod – Drug Conjugates
di: Nicole M. Warne, et al.
Pubblicazione: (2024)

What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High‐Dose Methotrexate Use in Pediatric Malignancies
di: Zachary L. Taylor, et al.
Pubblicazione: (2025)

Oral Adverse Drug Events in Patients With Psoriasis Receiving Immunosuppressive Therapy: A Multicenter Cohort Study
di: Matthew H. Lanehart, et al.
Pubblicazione: (2025)

Successful Management of Relapsing Primary Focal Segmental Glomerulosclerosis With Tacrolimus and Mycophenolate Multitarget Therapy
di: Frank Lee, et al.
Pubblicazione: (2025)

Immunosuppressive Drugs in Early Systemic Sclerosis and Prevention of Damage Accrual
di: Murray Baron, et al.
Pubblicazione: (2025)

Quality Assessment of Therapeutic Drug Monitoring Assays of Therapeutic Antibodies Across Europe: An Update
di: James Bluett, et al.
Pubblicazione: (2025)

Gamma‐Glutamyl Cysteine Ligase Activity as a Proxy for Human T Cell Function and Drug‐Induced Immunosuppression
di: Francisco Fueyo‐González, et al.
Pubblicazione: (2025)

Clinical Significance and Management of Atrioventricular Block Associated With Bradycardic/Antiarrhythmic Drug Therapy: Drug‐Induced or Drug‐Revealed?
di: Dimitrios Sfairopoulos, et al.
Pubblicazione: (2025)

Saliva Based Clozapine Therapeutic Drug Monitoring: A Systematic Review
di: Tessa Rademaker, et al.
Pubblicazione: (2025)

Corrigendum: Gamma‐Glutamyl Cysteine Ligase Activity as a Proxy for Human T Cell Function and Drug‐Induced Immunosuppression
di: Francisco Fueyo‐González, et al.
Pubblicazione: (2025)

Drug-Induced Partial Immunosuppression for Preclinical Human Tumor Xenograft Models.
di: Gorbushin, Anton K, et al.
Pubblicazione: (2025)

The Impact of Standard Versus Weight‐Based Maintenance Dosing of Fosphenytoin on Achieving Therapeutic Drug Levels
di: Madison Milby, et al.
Pubblicazione: (2025)

Precision Dosing, Therapeutic Drug Monitoring, and Clinical Pharmacokinetics in Pediatric Kidney Transplant Patients: Principles and Practice With Emphasis on Low‐ and Middle‐Income Countries
di: Paulo Caceres Guido, et al.
Pubblicazione: (2025)

Beyond ‘One Size Fits All’: Abatement of Linezolid‐Induced Thrombocytopenia Through Therapeutic Drug Monitoring and Precision Dosing—A Case Study
di: Kennedy C. Concannon, et al.
Pubblicazione: (2026)

Application of Model‐Informed Drug Development in Dose Selection and Optimization for siRNA Therapies
di: Ye Yuan, et al.
Pubblicazione: (2024)

Phase 1 Evaluation of the Bioequivalence and Drug‐Drug Interaction Potential of a Novel Fixed‐Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine
di: Hyung Soon Lim, et al.
Pubblicazione: (2024)

Therapeutic Advances in Drug Safety
Pubblicazione: (2019)

Biomarker‐Based Prediction of OATP1B1 Activity in Clinical Routine—Investigating Coproporphyrins as Markers for Drug–Drug–Gene Interactions
di: Leila Potzel, et al.
Pubblicazione: (2026)

Therapeutic Drug Monitoring: A Tool to Optimize Treatment of Inflammatory Joint Diseases
di: Silje W. Syversen, et al.
Pubblicazione: (2024)

Pharmacokinetics of Perampanel in Danish Paediatric Patients With Epilepsy Based on Therapeutic Drug Monitoring
di: Sara Angelucci, et al.
Pubblicazione: (2026)

Exploring the Therapeutic Potential of Antidiabetic Drugs in Cardiac Arrhythmia Management: A Drug Target Mendelian Randomization Study
di: Zheng‐Qi Song, et al.
Pubblicazione: (2025)

Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers
di: Mariam A. Ahmed, et al.
Pubblicazione: (2024)

Molecular-Size Control of Properties of Therapeutic Nano-Paper Allows for Selective Drug Storage in Small Doses
di: Erbes, Elisabeth, et al.
Pubblicazione: (2025)

From Ethnopharmacology to Drug Discovery: The Therapeutic Potential of Anisomeles indica
di: Yihao Long, et al.
Pubblicazione: (2026)

Assessment of Dosing Strategies for Pediatric Drug Products
di: Zachary L. Taylor, et al.
Pubblicazione: (2024)

Dose Determinations at Drug Approval Reviews: FDA‐Approved Drugs in Past 5 Years
di: Sachiko Mita, et al.
Pubblicazione: (2025)